chrisvoncsefalvay/vaers-outcomes huggingface dataset:
It was reported in a published article, that a 17 year old pt with no history of atopy, was vaccinated on an unknown date with a dose of MMR II. Secondary therapy included a dose of DT. Within one hour post-vaccination, the pt developed anaphylaxis with facial flushing, SOB, nausea, lightheadedness and numbness in legs. The pt was treated with epinephrine, IM diphenhdyramine, IV hydrocortisone and D5W. The pt's outcome was not reported. Upon internal review, anaphylaxis, facial flushing, SOB, nausea, lightheadedness, and numbness in legs were determined to be other important medical events (OMIC). Additional info is not expected. It was reported that other patients also developed adverse experiences following vaccinations (WAES0310USA01792, WAES0310USA01902, WAES0310USA01904, WAES0310USA01905 and WAES0310USA01906).
presents to ED on 9/17/21 with leg pain and lump in leg, weakness starting 9/16/21        discharged to home on aspirin 325 mg daily 9/29/21: pt re-presents to ED with no improvement and another lump in leg. Duplex preformed        plan to dispense Eliquis and schedule a follow up Duplex in 3-4 weeks
JUL96 passed out/throat tightened/had flu-like sx;nurse took blood;pt laid down 1hr then returned to work;pt taken to hosp spent 5hr then released;
I had soreness in my arm the next day and an A-fib episode. I have a history of heart arrhythmias that usually last 8-11 hours at a time, but this episode lasted longer. On the night of February 1, I had a shorter episode but I went to the cardiologist on February 2. He ran tests that showed everything was ok and prescribed the drug Multaq.
On 10/13/04, when I woke up and tried getting out of bed, the room spun so violently that I thought I was going to pass out! When I tried laying down the same thing happened. When I did manage to get out of bed, I felt dizzy and extremely nauseated. I called my husband at work who called a friend to come check on me. Everytime I tried to lay down, the room seemed to spin out of control. Even when my friend did manage to help me back to bed, the extreme dizziness and nausea persisted.
This case was reported by a physician via call center representative and described the occurrence of pain in a 69-year-old male patient who received Shingrix for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix (subcutaneous). On an unknown date, less than a year after receiving Shingrix, the patient experienced pain, chills, headache, injection site erythema, injection site swelling, injection site induration, distress gastrointestinal, nausea, fatigue and intramuscular formulation administered by other route. On an unknown date, the outcome of the pain, chills, headache, injection site erythema, injection site swelling, injection site induration, distress gastrointestinal, nausea and fatigue were recovered/resolved and the outcome of the intramuscular formulation administered by other route was unknown. It was unknown if the reporter considered the pain, chills, headache, injection site erythema, injection site swelling, injection site induration, distress gastrointestinal, nausea and fatigue to be related to Shingrix. Additional details were provided as follows: The patient was the reporting healthcare professional. The patient was unsure that he received the 1st dose of Shingrix in March 2018 or April 2018. The patient stated that the dose was inadvertently administered subcutaneously instead of the approved intramuscular, which led to intramuscular formulation administered by other route. The patient stated that he developed three days worth of aches, pains, chills, headache, gastrointestinal distress, nausea, fatigue, site swelling, redness and induration. All symptoms resolved after three days. The patient had not receive his 2nd dose in the recommended time frame due to product supply issue, refer case US2018227880. The healthcare professional consented for follow up, but did not provide his address. The healthcare professional did not have vaccine information for this adverse events.
Pt recvd 3 doses of Engerix-B for the prevention of Hep B vax on 07SEP90, 17OCT90, & 19MAR91; pt did not convert positive for HBSAB; No tx given; Reported indicated pt will recvd 1-2 extra doses of vax to try to get pt to convert;
4/25/03: seen in office, rash for 1 week, started on back, went to front, right side.
Hello,  I just wanted you to know that pt. had a reaction to the COVID booster.  She didn't feel good Tuesday evening after she got it.  Was up most of the night feeling dizzy and had a headache.  She threw up Wednesday morning.  She came to tell me that she was not feeling well and I noticed that she was pale.  I no more told her to go ahead and lay back down and she passed out.  She did rest all day and finally felt better late last night
Vaccine received @ 0721, observation @ 0722. 0735 pt. states, "feeling itchy on body" appears flushed and clammy to touch. 02 :97%, BP 115/70,HR78,25mg chew. Benadryl admin. reassess 0740 pt states, "feeling better". Extended observation done and constant assessment. Pt states" very sensitive to Benadryl", her supervisor. is made aware of situation. 0810 patient appears flushed again  assess and monitor 02:98%, BP 110/70. patient is talking with staff and is very anxious and states "her right arm and chest are sore" . lung sounds auscultated, slightly diminished in right lower lobe. Pt informed that a follow up is needed we recommend going with EMS. 0825 EMS called, pt placed in wheelchair. 0834 epi 0.3mg
As of three hours following being given the incorrect vaccine, the patient has a headache and a stuffy nose.
I did not have an adverse reaction to the vaccine. I started not feeling well on 02/23/2023 with a sore throat, stuffy head, fatigue and a cough. I tested positive for COVID-19 on 03/10/2023. I did not contact my doctor as it already been two weeks. I took acetaminophen and a cough medication to help with symptoms. I started feeling bad again and retested for COVID-19 and it was positive on 03/26/2023. As of today, I still have a scratchy throat and I cough sometimes.
No additional AE; HCP reported VARIVAX,MMR, and IPV  was administered after a temperature excursion.; This spontaneous report was received from a nurse and refers to a 7-year-old male patient.  The patient's medical history, concurrent conditions , concomitant therapies and previous drugs reactions or allergies were not reported.  On 26-JAN-2023, the patient was vaccinated with an improperly stored  varicella virus vaccine live (oka/merck) (VARIVAX)  lot #W008711, expiration date: 14-MAR-2024, administered for prophylaxis (strength, and route of administration were not provided); measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, unk, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided); and  polio vaccine inact (IPV), unk, administered for prophylaxis (strength, formulation, lot #, expiry date, and route of administration were not provided) ) following a temperature excursion of -10.5 degrees Celsius for 1hour 34 minutes (product storage error). It was stated that a data logger was involved and no previous temperature excursion occurred. No adverse reaction reported.  This is one from several cases from the same reporter.
This non-serious medically confirmed report (initial receipt 10-Sep-2015) concerns an 88 year old male patient. On the 10-Sep-2015, the patient received AFLURIA (batch number not reported) for the prevention of influenza. The patient received one injection and it was a 1mL dose in the left arm, instead of 0.5 mL. The patient was fine and had no complaints. It was an overdose. No treatment was received. Outcome was recovered.
Flu and UTI,  stomach pain, severe vomiting, diarrhea, dehydration, fatigue, weakness, headache, bodyaches, eye pain, chest pain, incontinence
Reaction occurred on 2/7/21 (about 48 hours after first dose): Severe dizziness and blurred vision for 10 minutes. Patient has no prior history of dizziness, vertigo, or blurred vision.
Muscle pain; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle pain) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Muscle pain) and NAUSEA (Nausea). At the time of the report, MYALGIA (Muscle pain) and NAUSEA (Nausea) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood glucose: increased (High) Spike in blood sugar.
This non-serious spontaneous case, initially received from other health professional (nurse), on 12-Oct-2018, concerns a 35-year-old, adult female pregnant patient. On 10-Oct-2018, the pregnant patient was administered an expired suspect vaccine FLUCELVAX QIVc [batch number: 195215, expiry date: 30-Apr-2018, dose, route of administration and anatomical location: not reported]. At the time of this report, no adverse events were reported. This case was linked to case 201804438 due to the same reporter.
Moderate fatigue and serious body ache.  Took Advil with lots of rest.  Symptoms stopped on 3rd day after injection.
ERROR: UNUATHORIZED AGE GROUP (15 years old, Pfizer EUA approved only for persons 16 years and older at time of administration. Parent signed consent form with incorrect DOB indicating age greater than 16 yo).  Event discovered and forwarded for VAERS reporting. Signs and symptoms: None known Diagnosis and treatment: None known Outcome: No adverse reaction reported
Information has been received from a nurse concerning a 16 year old patient with a history of hepatitis A who on 27-JUL-2009 was vaccinated with a second dose of VARIVAX (Merck) (lot # 664692/0694Y) 0.5ml. Suspect secondary therapy include VAQTA (MSD). On 27-JUL-2009 after getting the vaccine the patient experienced blanching and cellulites. On 28-JUL-2009 the patient was seen in the office. On unspecified date the patient recovered. This is one of three reports from the same source. Follow up information has been received on 20-OCT-2009 via telephone call from a registered nurse who reported that the patient experienced cellulitis previously reported as cellulites. No further information is available.
Customer tolerated vaccination well (given at 1:30pm).  Advised customer to wait 15 minutes for observation and to inform Pharmacy any changes in condition. Customer drunk water during observation time. Customer complained of nausea and headache symptoms at 1:40 p.m. Had her wait additional time to monitor condition. Customer felt better after 2:21p.m. and left store with no further reactions.
This spontaneous report was received from an office manager via a company representative referring to a female adolescent patient of unknown age (between the age of 13 and 14 years old). The patient's medical history, concurrent conditions or concomitant therapies were unknown. In 2018 (also reported as: "about one year ago"), the patient was vaccinated with the first dose of GARDASIL 9 (strength, route, anatomical location, lot number and expiration date were unknown) for prophylaxis. On an unknown date, the patient experienced a "cyst on ovaries" after having GARDASIL 9 administered. The patient completed one injection of a two dose series. Additionally, it was reported that no treatment was given, no laboratories diagnostic or studies were performed. The case did not involve caner or overdose. At the time of the report, the outcome of ovarian cyst was not provided. The reporter did not assess the relatedness between ovarian cyst and GARDASIL 9.
Information has been received from a pharmacist referring to a 71 year old patient of unknown gender. On 02-JUN-2015, the patient who was indicated for ZOSTAVAX was vaccinated with a dose of (Oka/Merck) VARIVAX (dose, strength and route were unknown, lot # L002870, expiry date: 27-JAN-2017). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
At 14:20, vaccines administered and at 14:45 the pt was discharged with drill instructor. At 15:20, had SOB and bilateral wheezing. O2 sat 94%, pulse 118, RR 30. Medicines given were oxygen, Benadryl, epinephrine, Solu-Medrol, albuterol nebulizer (2). Pt with a rash over his arms. Symptoms improve and is transported to a special care unit for overnight observation. Temperature 98.7F.
The day after I got my 2nd shot, I felt really sick. I was dizzy, nauseous, extremely fatigued to where I almost passed out a couple times. My biggest concern was the fatigue and my blood pressure tanking. It got down to 90/60. The issue is that for the months following I had really bad gastrointestinal issues. I was constipated at times, and had diarrhea at other times, going about 8-10 times before it even hit noon (my average before this was once a day or not at all). I was dehydrated from using the bathroom so much so I was dizzy nauseous, light-headed, and fatigued constantly. I had a lot of abdomen pain and soreness. All of these symptoms occured after I got my 2nd dose and have continued until this very day. I went to my primary doctor in May/June, but she believed that I was having too many unrelated symptoms and that it was probably something I was eating (since I do have a few food allergies). I basically wasn?t having it and I went to get a second opinion at a diagnostic gastrointestinal doctor. I got a colonoscopy and endoscopy from him back in July and  it was concluded that I had an ulcer in my colon, among other things like a polyp (also in my colon), gastritis, esophagitis, and internal hemorrhoids. Now the only one that is really important to this story, however, is the ulcer. I was told by the doctor?s assistant in my follow up appointment that I also have ischemic colitis and that that was how my ulcer was most likely formed- just having a drop in blood pressure for an extended period of time, not getting enough blood flow to my colon, causing an ulcer. She told me the ulcer will heal as my blood pressure rises, but I?m my whole life I?ve always had lower than average blood pressure so it can?t get high enough and I?m in a bit of a pickle.
Patient tested positive for COVID on 01/09/2021. Patient received out patient monoclonal antibody treatment 01/10/2021. Resident received outpatient IV fluid bolus (D5NS 1 liter) on 01/15/2021.
Received vaccine 4/1 at 7pm; woke up 4/2 at 6am with a sore back and shoulders.  11am: Severe nausea and excessive drooling, eyes watering.  11:30am: Extreme nausea with vomiting, eyes continued to water and drooling.  Took Zofran for nausea, headache and severe body aches, joint pain in hips, feet and knees lasted for approx. 5 hours.  Temp 100.2 and body aches throughout the night x 8-10 hours.
Swelling/induration of tricep area from injection site to elbow, chills, sweats. Diphenhydramine 50 mg TID.
LIGHT SENSITIVITY; SOUND SENSITIVITY; BODY ACHES; MIGRAINE HEADACHE; CHATTERING TEETH/CHILLS; FEVER; HEADACHES; This spontaneous report received from a patient concerned a 41 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced light sensitivity, sound sensitivity, body aches, migraine headache, chattering teeth/chills, fever, and headaches. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 103 (units unspecified). Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the migraine headache, chattering teeth/chills, fever, light sensitivity, sound sensitivity, body aches and headaches was not reported. This report was non-serious.
Felt dizzy, cold, had calicus on both hands, and had fever. Took Tylenol. Went to the emergency room to get checked out. Doctor stated adverse reaction to the meningitis immunization. The doctor gave Motrin.
Last week I started developing aches and pains, sore throat and other upper respiratory symptoms, I took other counter medicines to treat the symptoms. I took 5 COVID-19 Home test from Tuesday until Friday and 3 of them were positive. I had a telehealth visit and he prescribed Teflon pearls and a cough medication with codeine. I still feel pretty bad but I am starting to feel a little better. I am not running a fever but I am still in recovery. The sore throat has gotten better but I am still having the fatigue and cough currently.
CONFIRMED CLINICAL VACCINE FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a other company concerned a patient of an unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: high blood pressure, and allergy (Unspecified). The patient had previously received covid-19 vaccine ad26.cov2.s (Dose number in series: 1) (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, dose 1, 1 in total, administered in left arm on 23-APR-2021 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (Dose number in series: 1). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series: 2) (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, dose 2, 1 in total, administered in right arm on 13-NOV-2021 for covid-19 prophylaxis. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 2022 (Date and month unspecified), the patient experienced covid and tested positive which was confirmed covid-19 infection and confirmed clinical vaccine failure (Dose number in series: 2). Laboratory data included: COVID-19 virus test Positive The patient received non-company suspect drug Paxlovid (form of admin, route of admin were not reported, batch number: Unknown and expiry: Unknown) dose was not reported, administered from 13-JUL-2022 to 17-JUL-2022 for treatment of COVID-19. On 2022 (Date and month unspecified), the patient tested negative 7 day (unspecified) after testing positive. Laboratory data included: COVID-19 virus test Negative. On 2022 (Date and month unspecified), the patient had rebound case which tested positive again 14 day (unspecified) after negative test. Laboratory data included: COVID-19 virus test Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable and with Paxlovid was not reported. The patient was recovering from confirmed covid-19 infection, and the outcome of confirmed clinical vaccine failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint and reference number requested.; Sender's Comments: V0: 20220837895-covid-19 vaccine ad26.cov2.s-confirmed clinical vaccine failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
Noticed enlarged lymph node located under left jaw about 1.5 weeks after booster vaccination. Enlarged lymph node remains present today. Notified A NP, ultrasound of the neck ordered and obtained at the end of November. Results of ultrasound were benign. Continuing to monitor site.
Marked erythema, swelling on (R) arm with  body aches N / V / fever.
Swelling and tenderness at the injection site. Fever of 100.1 df. Very weak. Rash. Given Benadryl for the rash on 09/14/2010 at 8:00 PM.
her arm got sore at the injection site; This is a spontaneous case is received from a contactable consumer (patient). A 71-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EN6200; Expiration Date: Unknown) via an unspecified route of administration, administered in arm left on 16Mar2021 as a single dose for covid-19 immunisation. Medical history included Type II Diabetes (Jun 2020), Blood Pressure runs high, History of Breast Cancer, History of having skin cancer removed, Restless leg syndrome. Concomitant medications included atorvastatin (ATORVASTATIN) for blood cholesterol, ropinirole (ROPINIROLE) taken for restless legs syndrome, metformin (METFORMIN) taken for diabetes mellitus from Jun2020 and ongoing, glimepiride (GLIMEPIRIDE) taken for diabetes mellitus, atenolol (ATENOLOL) taken for blood pressure measurement, tocopherol (VITAMIN E D ALPHA TOCOPHEROL) taken for an unspecified indication, acetylsalicylic acid (ASPIRINE) taken for an unspecified indication. The patient experienced her arm got sore at the injection site on 16Mar2021. The outcome of the event was recovered.  No follow-up attempts are needed. No further information is expected.
shoulder pain since the time of vaccine persisting until first visit with me on 12/9/21.  diagnosed by me as SIRVA
Hospitalized 10/23/2021; COVID-19 positive 10/19/2021; fully vaccinated  BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: MD  Admission Date: 10/23/2021 Discharge Date: 10/25/2021  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hyponatremia [E87.1] Weakness [R53.1] Generalized weakness [R53.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE:  Patient was admitted on 10/23/2021 for generalized weakness, unclear etiology at this point likely suspect component of dehydration from poor oral intake, deconditioning in the setting of recent COVID-19 infection. The patient was diagnosed woth COVID-19 on 10/19 status post monoclonal antibody. The patient currently is not in respiratory distress and has remained on room air, he is not a candidate for steroids or remdesivir. The patient's most bothersome symptom is diarrhea he was encouraged to eat yogurt and advanced diet as tolerated. The patient was also given a prescription for imodium but encouraged to use this sparingly with his underlying COVID-19 diagnosis. The patient was noted to have mild hyponatremia upon admission this improved to 129 with PO intake. Recommend checking BMP in 1 week to ensure this improved.  The patient will be returning home with family and assistance.
I noticed a lump on my collar bone that was point tender. I seen my Dr. and had an ultrasound,  it was diagnosed with large lymph node was increase internal vascularity, there are several other lymph nodes with the same diagnoses but you can only feel one.  I still have this and dealing with it.
Tingling, numbness started in fingers and feet the day after receiving vaccine, progressed to weakness and eventually after 2 wks was unable to walk or lift arms. Hospitalized in ICU and treated with IVIG, PT and OT.
Arm ached and was swollen with bruise at injection site and red in a large oval almost to my elbow: this began within 3 hours from injection and now, 3 days later 7/17, continues to ache, interrupt sleep. Black and blue site and large area of redness continues to be visible and swollen. Within 3 hours of the injection I was extremely fatigued and headache and muscle aches, esp in lower back, no appetite. This continued through 7/16. Took TYLENOL in addition to my usual ibuprofen and slept for 2 days. I remain tired and my arm aches. I called the pharmacist to thank her for warning me I might have side effects. This is the first time I have had a reaction to a shot.